$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is capmatinib (Tabrecta) available in China? Is it easy to buy?
2025-10-19 11:44:20
Check Details
The correct way to purchase Capmatinib (Tabrecta)
2025-10-19 11:44:20
Check Details
How to treat adverse reactions caused by capmatinib (Tabrecta)?
2025-10-19 11:44:20
Check Details
The latest price of Capmatinib (Tabrecta) in 2024 published on the entire network
2025-10-19 11:44:20
Check Details
The latest prices for a box of different versions of Capmatinib (Tabrecta) announced
2025-10-19 11:44:20
Check Details
Is there a suitable way to purchase genuine Amivantamab?
2025-10-19 11:44:20
Check Details
Can Amivantamab effectively treat the disease?
2025-10-19 11:44:20
Check Details
Amivantamab price list
2025-10-19 11:44:20
Check Details
How to treat adverse reactions caused by Amivantamab?
2025-10-19 11:44:20
Check Details
The latest prices for a box of different versions of Amivantamab are announced
2025-10-19 11:44:20
Check Details
Where can I buy Amivantamab more reliably?
2025-10-19 11:44:20
Check Details
Is Amivantamab available in China? Is it easy to buy? _ Kanghule
2025-10-19 11:44:20
Check Details
1
2
...
10210
10211
10212
10213
10214
10215
10216
10217
10218
10219
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
2
Lemborexant: Mechanism of Action and Clinical Profile of a Dual Orexin Receptor Antagonist
3
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
4
Avutometinib Plus Defactinib: A Precision Therapy for KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer
5
Mechanism and Clinical Value of Pemafibrate in Triglyceride Lowering
6
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
7
Pegloticase (Krystexxa) Complete Medication Guide
8
Vemurafenib (Zelboraf) Complete Medication Guide
9
Guide to Long-Term Ramipril Use: Safety and Renal Function Management
10
Mechanism and Clinical Positioning of Leflunomide: A Comprehensive Guide to csDMARDs
11
Comprehensive Clinical Guide to Risankizumab (Skyrizi): Dosing, Contraindications, and Safety
12
Management Strategies and Long-Term Outcomes Following 6 Months of Pegloticase (Krystexxa) Therapy